Expression of the Chemokine Receptor CCR7 in the Normal Adrenal Gland and Adrenal Tumors and Its Correlation with Clinical Outcome in Adrenocortical Carcinoma

Simple Summary:& nbsp;The chemokine receptor CCR7 plays an important role in immune function and lymphoid trafficking and has been shown to be expressed in several malignant tumors with evidence for a role in tumor cell progression and clinical outcome. Here, we investigated the expression of CCR7 in normal adrenal glands, adrenocortical adenomas, and adrenocortical carcinomas. CCR7 was expressed across all adrenal tissues. However, CCR7 protein or mRNA expression did not significantly influence patient survival in adrenocortical carcinoma, but it could play a role in adrenocortical homeostasis. Background: The chemokine receptor CCR7 is crucial for an intact immune function, but its expression is also associated with clinical outcome in several malignancies. No data exist on the expression of CCR7 in adrenocortical tumors. Methods: CCR7 expression was investigated by qRT-PCR and immunohistochemistry in 4 normal adrenal glands, 59 adrenocortical adenomas, and 181 adrenocortical carcinoma (ACC) samples. Results: CCR7 is highly expressed in the outer adrenocortical zones and medulla. Aldosterone-producing adenomas showed lower CCR7 protein levels (H-score 1.3 & PLUSMN; 1.0) compared to non-functioning (2.4 & PLUSMN; 0.5) and cortisol-producing adenomas (2.3 & PLUSMN; 0.6), whereas protein expression was variable in ACC (1.8 & PLUSMN; 0.8). In ACC, CCR7 protein expression was significantly higher in lymph node metastases (2.5 & PLUSMN; 0.5) compared to primary tumors (1.8 & PLUSMN;0.8) or distant metastases (2.0 & PLUSMN; 0.4; p < 0.01). mRNA levels of CCR7 were not significantly different between ACCs, normal adrenals, and adrenocortical adenomas. In contrast to other tumor entities, neither CCR7 protein nor mRNA expression significantly impacted patients' survival. Conclusion: We show that CCR7 is expressed on mRNA and protein level across normal adrenals, benign adrenocortical tumors, as well as ACCs. Given that CCR7 did not influence survival in ACC, it is probably not involved in tumor progression, but it could play a role in adrenocortical homeostasis.

Automated summary

CCR7 is expressed in normal adrenal glands, adenomas, and adrenocortical carcinomas, but its expression does not significantly impact patient survival in adrenocortical carcinoma. It may play a role in adrenocortical homeostasis.